Vor Biopharma (VOR) Treasury Shares (2020)

Vor Biopharma (VOR) has reported Treasury Shares for 6 consecutive years, with $346325.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares changed N/A year-over-year to $346325.0; the TTM figure through Mar 2026 stood at $346325.0 (changed N/A YoY), while the FY2025 annual figure was $186325.0, up 182.11% from the prior year.
• Treasury Shares grew to $346325.0 in Q1 2026 per VOR's latest filing, from $186325.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $1.4 million in Q4 2022 and bottomed at $66046.0 in Q4 2024.
• Historically, Treasury Shares has averaged $628455.4 across 5 years, with a median of $346325.0 in 2026.
• Annual changes were most pronounced in 2024 — Treasury Shares tumbled 94.07% — and 2025, when it soared 182.11%.
• Vor Biopharma's Treasury Shares stood at $1.4 million in 2022, then retreated by 22.15% to $1.1 million in 2023, then sank by 94.07% to $66046.0 in 2024, then jumped by 182.11% to $186325.0 in 2025, then surged by 85.87% to $346325.0 in 2026.
• Business Quant data shows VOR's Treasury Shares at $346325.0 in Q1 2026, $186325.0 in Q4 2025, and $66046.0 in Q4 2024.